Cargando…
Inhibition of TRF2 Leads to Ferroptosis, Autophagic Death, and Apoptosis by Causing Telomere Dysfunction
BACKGROUND: Gastric cancer (GC) is an aggressive malignancy with a high mortality rate and poor prognosis. Telomeric repeat-binding factor 2 (TRF2) is a critical telomere protection protein. Emerging evidence indicates that TRF2 may be an essential treatment option for GC; however, the exact mechani...
Autores principales: | Yang, Qiuhui, Nie, Ziyang, Zhu, Yukun, Hao, Mingying, Liu, Siqi, Ding, Xuelu, Wang, Feng, Wang, Fei, Geng, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129434/ https://www.ncbi.nlm.nih.gov/pubmed/37113742 http://dx.doi.org/10.1155/2023/6897268 |
Ejemplares similares
-
TRF2 Mediates Replication Initiation within Human Telomeres to
Prevent Telomere Dysfunction
por: Drosopoulos, William C., et al.
Publicado: (2020) -
TRF1 and TRF2 binding to telomeres is modulated by nucleosomal organization
por: Galati, Alessandra, et al.
Publicado: (2015) -
Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2
por: Opresko, Patricia L., et al.
Publicado: (2005) -
The N-terminal domains of TRF1 and TRF2 regulate their ability to condense telomeric DNA
por: Poulet, Anaïs, et al.
Publicado: (2012) -
Mir-23a induces telomere dysfunction and cellular senescence by inhibiting TRF2 expression
por: Luo, Zhenhua, et al.
Publicado: (2015)